Stay updated on Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial

Sign up to get notified when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:16:07.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Footer now mentions Tuberculosis and includes a link to the Genetic and Rare Diseases Information Center. The revision tag has been updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:36:59.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The only visible change is a footer revision update from v3.4.0 to v3.4.1, with no impact on study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T22:38:22.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    UI updates include showing the glossary toggle and minor wording changes such as capitalization in 'Last Update Submitted' and 'QC Criteria' as well as a version reference updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:12:26.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. No changes were made to the study details or page content.
    Difference
    0.0%
    Check dated 2026-01-14T04:23:16.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    New location sections were added for Illinois, New York, North Carolina, Pennsylvania, Texas, Gauteng, West Cape, and Patumwan, replacing the previous location blocks. The page revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure footer was removed.
    Difference
    0.8%
    Check dated 2025-12-23T22:05:56.000Z thumbnail image

Stay in the know with updates to Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.